Pfizer, Inc. Common Stock (PFE) stock analysis

PFE · Pfizer, Inc. Common Stock

Latest recorded price: USD 28.86

Model-estimated fair value: USD 10.38. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - General

At $28.86, PFE trades 178.0% above the model's base-case value of $10.38. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $6.27 in the conservative case and $14.99 in the optimistic case, with a valuation confidence score of 55/100. About 71% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth -14.6%, free cash flow margin 14.5%, ROIC 4.3%. The model flags 2 risk signals for this company (1 high severity).

Similar companies in Healthcare